Benzyl (3-hydroxycyclopentyl)carbamate, 95.0%, 500mg

1,2,4,9-Tetrahydrocarbazol-3-one, 97%, 100mg

monoclonal de souris anti-GAPDH, clone 6C5, 0,2 ml

Methyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carboxylate, 95.0%, 1g

3-Cyano-2,6-dihydroxy-4-(trifluoromethyl)pyridine, 95.0%, 1g

3-((4-fluorophenyl)sulfonyl)propanoyl chloride, 95.0%, 2.5g

1-(4-(Trifluoromethyl)phenyl)cyclobutanecarbonitrile, 95.0%, 10g

Tantalate de lithium en poudre 99,9% 10 g

Acetic acid, 2-methoxy-, (1S,2S)-2-[2-[[3-(1H-benzimidazol-2-yl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, hydrochloride (1:2), 97%, 5mg

3-Hexylthiophene, 99.0%, 25g

2,6-Dibromo-3,5-difluoroisonicotinic acid, 95.0%, 50mg

3,6-Difluoropyrazine-2-carboxamide, 95.0%, 1g

(2S,4S)-4-AMINOPYRROLIDINE-2-CARBOXYLIC ACID DIHYDROCHLORIDE, 95.0%, 1g